Atika Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-94,000
| Closed | -$2.52M | – | 88 |
|
|
2019
Q3 | $2.52M | Sell |
94,000
-6,000
| -6% | -$161K | 0.53% | 50 |
|
|
2019
Q2 | $2.71M | Hold |
100,000
| – | – | 0.53% | 60 |
|
|
2019
Q1 | $3.47M | Buy |
+100,000
| New | +$3.47M | 0.7% | 45 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 90 |
|
|
2018
Q3 | – | Sell |
-127,000
| Closed | -$4.8M | – | 99 |
|
|
2018
Q2 | $4.8M | Buy |
+127,000
| New | +$4.8M | 0.92% | 34 |
|
|
2018
Q1 | – | Sell |
-70,000
| Closed | -$3.41M | – | 86 |
|
|
2017
Q4 | $3.41M | Buy |
70,000
+12,000
| +21% | +$584K | 1.32% | 32 |
|
|
2017
Q3 | $3.13M | Buy |
+58,000
| New | +$3.13M | 0.9% | 34 |
|
|
2016
Q2 | – | Sell |
-27,500
| Closed | -$561K | – | 70 |
|
|
2016
Q1 | $561K | Sell |
27,500
-38,500
| -58% | -$785K | 0.34% | 38 |
|
|
2015
Q4 | $3.4M | Sell |
66,000
-62,000
| -48% | -$3.19M | 1.75% | 22 |
|
|
2015
Q3 | $5.46M | Buy |
128,000
+30,000
| +31% | +$1.28M | 2.68% | 11 |
|
|
2015
Q2 | $4.46M | Buy |
98,000
+9,000
| +10% | +$410K | 2.01% | 12 |
|
|
2015
Q1 | $3.38M | Buy |
+89,000
| New | +$3.38M | 2.26% | 12 |
|